AIM
IBB icon

Arcadia Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Arcadia Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-495
Closed -$56K – 296
2015
Q4 		$56K Buy
+495
New +$53.7K 0.02% 163

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Arcadia Investment Management's IBB Position: Q1 2016 in Review

Arcadia Investment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 495 shares — an estimated $56K sold.

Arcadia Investment Management first reported a position in IBB in Q4 2015 and held it in 1 quarter. The position peaked at $56K in Q4 2015. 414 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

  • Arcadia Investment Management reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
  • Arcadia Investment Management sold 495 iShares Biotechnology ETF shares in Q1 2016, an estimated $56K.
  • Arcadia Investment Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 1 quarter.
  • Arcadia Investment Management's iShares Biotechnology ETF position peaked at $56K in Q4 2015.
  • 414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Arcadia Investment Management's 13F filing for Q1 2016, filed 29 Apr 2016.